Ulzol

Quick links to important sections

Medically reviewed

Marina Burgos

Last updated on 10/01/2026

This page provides general, reference-level information compiled from official medical sources. It is not a substitute for professional medical advice, diagnosis, or treatment. For decisions about your health, please consult a qualified healthcare professional.

Overview of Ulzol

Quick Facts

Property Description
Active ingredient Ulzol (INN)
Form Delayed-release capsule or tablet
Pharmacological class Protonic Pump Inhibitor (PPI)
Common use Sustained gastric protection
Origin Synthetic compound

What Type of Medicine is Ulzol?

Ulzol is an acid-suppressing medication belonging to the Protonic Pump Inhibitor (PPI) pharmacological class, which works by reducing the amount of acid the stomach produces. It is a widely used prescription drug, identified by its non-proprietary name, Ulzol (INN). This drug class is recognized for its lasting effect on acid suppression.

As an oral medication, Ulzol is typically provided as a delayed-release capsule or tablet. This specialized form is a defining characteristic of Ulzol's mechanism; the enteric coating ensures the medicine remains intact until it passes safely through the stomach's highly acidic environment. This ensures proper absorption to target the acid-producing pumps.


Is Ulzol Natural or Synthetic, and What is the Main Ingredient?

The core of the medicine is a synthetic chemical compound, meaning it is precisely engineered in a controlled laboratory setting for guaranteed purity and consistent quality. Its Active Pharmaceutical Ingredient (API) is Ulzol, which is responsible for the drug’s primary action.

This method of production ensures a standardized, highly reliable dose. The other components are inactive ingredients (excipients) that safely carry the API and ensure proper absorption within the digestive system, making the formulation suitable for various patient needs.


What is Ulzol Generally Used to Achieve?

The general purpose of Ulzol is to provide sustained gastric protection by consistently lowering stomach acid levels over time. It is primarily designed to facilitate the healing and maintenance of the healthy lining of the esophagus and stomach.

By creating a more neutral internal environment, Ulzol helps manage the discomfort associated with excessive acid and provides a long-term protective benefit.

What side effects are possible with Ulzol?

Possible Side Effects and Safety Information

The safety profile of Ulzol is officially documented by regulatory authorities, classifying potential adverse reactions primarily by frequency and the body system affected. These classifications distinguish between common, expected events and rare, clinically serious risks.

Common Adverse Reactions

Adverse reactions classified as Common typically involve the Gastrointestinal and Nervous Systems. These frequently include headache, abdominal pain, flatulence, nausea, vomiting, diarrhea, and constipation. These effects are often documented as being transient and may be more prominent at the start of treatment, according to the European Medicines Agency (EMA).

Serious Adverse Reactions and Long-Term Safety

Regulatory labeling notes several serious adverse reactions, although these are typically Rare events. These include the documented risk of bone fracture (hip, wrist, or spine), which is associated with prolonged use, generally one year or longer. Other serious risks include Acute Interstitial Nephritis (AIN), an acute kidney condition, and the potential for severe, persistent diarrhea related to Clostridium difficile-associated diarrhea (CDAD). Cyanocobalamin ( B12) deficiency has also been reported with use extending two years or more, as noted by the U.S. Food and Drug Administration (FDA).

Safety Considerations and Restrictions

Official prescribing information includes specific safety considerations for certain patient populations. Caution is advised for older adults due to the increased documented risk of bone fracture. Similarly, patients with severe hepatic impairment may require particular caution due to the drug's metabolism. The medicine is contraindicated in patients with a known hypersensitivity to the active substance or any PPI of the same chemical class.

Overdose and Emergency Response

Overdose and when to seek help

The information below summarizes the overdose manifestations and emergency actions documented in regulatory prescribing information for Ulzol (Omeprazole).

Officially documented overdose presentations and clinical experience indicate that high-dose ingestion, including up to 2400 mg, has generally resulted in a pattern of transient, non-severe symptoms. Observed clinical manifestations of overdose may include confusion, headache, flushing, and blurred vision. Other documented signs can affect the gastrointestinal system (nausea and vomiting) and the cardiovascular system (tachycardia).

Regulatory authorities explicitly state that no specific antidote is known for Ulzol overdose. Consequently, the official management procedure is mandated to be symptomatic and supportive treatment under medical supervision.

Required Emergency Actions

Action Mandated by Regulatory Labeling Rationale
Seek immediate medical attention. Required for assessment and supportive care.
Contact a Poison Control Center right away. Essential for professional guidance on overdose management.

All cases of suspected overdose require immediate professional assessment. The requirement to contact emergency services or a Poison Control Center establishes the necessary condition for official medical monitoring and supportive care, as documented in the drug's regulatory profile.

Therapeutic Uses of Ulzol

Quick Facts: Ulzol's Therapeutic Domains

  • Gastroesophageal Reflux Disease (GERD): May help manage symptoms such as heartburn and associated discomfort.
  • Erosive Esophagitis (EE): Used to support the healing of acid-related damage to the lining of the esophagus.
  • Ulcers: An option for treating duodenal and gastric ulcers.
  • H. pylori Eradication: Used in combination with specific antibiotics to address H. pylori bacterial infection associated with ulcers.
  • Hypersecretory Conditions: May be used for long-term management of conditions where the stomach produces excess acid, such as Zollinger-Ellison syndrome.

Ulzol is a medication used to manage conditions caused by excess gastric acid. The drug is a therapeutic option for individuals experiencing the symptoms of Gastroesophageal Reflux Disease (GERD), including frequent heartburn and associated discomfort. It may also support the healing of Erosive Esophagitis, which involves acid-related injury to the esophagus lining.

Physicians may utilize Ulzol for the treatment of both active duodenal ulcers and benign gastric ulcers. Furthermore, it is a component of combination therapy regimens designed to address Helicobacter pylori bacterial infection, which is often a contributing factor to duodenal ulcer recurrence. For chronic, rare conditions that result in the stomach producing excessive amounts of acid, such as Pathological Hypersecretory Conditions (e.g., Zollinger-Ellison syndrome), Ulzol serves as a suitable long-term management option.

Eligibility and Restrictions for Use

Who Can and Cannot Use Ulzol?

Ulzol's eligibility profile is strictly defined by regulatory documents, which establish population groups who are permitted, restricted, or contraindicated for use.

Contraindications and Restrictions

Category Official Regulatory Classification
Absolute Contraindication Patients with known hypersensitivity to Ulzol, any substituted benzimidazoles, or any component of the formulation. Co-administration with rilpivirine-containing products is also contraindicated.
Conditional Use/Restriction Patients with severe hepatic impairment (e.g., Child-Pugh Class C) require a maximum daily dose limitation. Malignancy must be excluded before treating patients presenting with certain severe gastrointestinal symptoms.

Age and Physiological Eligibility

Population Group Official Regulatory Status
Adults Eligible for all approved uses.
Pediatric Patients Approved for specific indications (e.g., GERD, Erosive Esophagitis) typically starting at one year of age. Safety and effectiveness are not established for infants under one year for most uses.
Renal Impairment Generally eligible for use; no dosage adjustment is typically specified.
Pregnancy/Lactation Conditional use only if the clinical benefit justifies the risk. Use during lactation is generally not recommended.

Regulatory documents define Ulzol eligibility by establishing absolute contraindications based on patient allergies and specific drug interactions. Eligibility is further delineated by minimum age requirements and conditional limitations, such as a maximum allowed dose for individuals with severe liver impairment.

What should I know about interactions with other medicines?

Interactions with other medicines and products

Ulzol's official interaction profile is primarily governed by its ability to inhibit the CYP2C19 enzyme and increase gastric pH. These two mechanisms affect the concentration and effectiveness of co-administered medicines, as documented in regulatory labeling.

Pharmacokinetic Interactions

Interaction Type Affected Medicines/Classes Practical Implication
Gastric pH Change Antivirals (e.g., Atazanavir, Rilpivirine, Nelfinavir), Antifungals (e.g., Ketoconazole, Itraconazole), Erlotinib Co-administration is generally avoided due to significantly decreased absorption and reduced drug effectiveness. The absorption of Digoxin may be increased, requiring monitoring, especially in the elderly.
Enzyme Inhibition ( CYP2C19) Cilostazol, Diazepam, Phenytoin, Warfarin Increased plasma concentrations of these medicines may occur, requiring therapeutic drug monitoring and potential dose adjustment by a healthcare provider.
Prodrug Metabolism Clopidogrel Reduced formation of Clopidogrel's active metabolite, which may result in less platelet inhibition. This combination requires careful clinical consideration.
Metabolic Induction Rifampicin, St. John's wort These agents may induce enzymes that metabolize Ulzol, leading to substantially decreased Ulzol exposure and potentially reduced efficacy.

Procedural Constraints

Co-administration with high-dose Methotrexate is officially noted for a risk of increased Methotrexate exposure. Temporary withdrawal of Ulzol should be considered in this context. Furthermore, official documentation notes that use for three years or longer may be associated with decreased absorption of Vitamin B12.

Mechanism of Action

Irreversible Enzyme Blockade at the Source

Ulzol's primary mechanism involves its role as an irreversible inhibitor of the H^+/ K^+-ATPase (proton pump) . This enzyme, located on the secretory surface of the gastric parietal cells, is the final molecular mechanism for acid secretion. The drug forms a permanent, covalent bond with specific cysteine residues on the pump, physically and non-competitively disabling its function. This blockade halts the final step of hydrogen ion ( H^+) efflux into the stomach lumen, resulting in a significant elevation of intragastric pH.

pH-Dependent Activation and Targeted Suppression

Ulzol functions as an inactive prodrug that requires a specific chemical step for activation. It is chemically converted into its active form only within the highly acidic environment of the parietal cell canaliculi. This activation mechanism ensures the drug concentrates its inhibitory effect specifically on pumps that are actively functioning on the secretory surface, leaving resting pumps spared. The resulting targeted suppression is limited in duration only by the rate at which the parietal cell synthesizes new, uninhibited enzyme proteins (cellular turnover), which determines the overall duration of acid suppression.

Dosage and Administration Information

How to Use Ulzol

The administration of Ulzol (Omeprazole) is based on specific protocols to ensure proper effectiveness and absorption. The primary route of administration is oral, utilizing dosage forms such as the delayed-release capsule, tablet, or oral suspension; an intravenous (IV) infusion form is also available for specific clinical settings.


Dosing and Frequency

Ulzol's dosing schedule is standardized by indication, but a general framework applies to the oral administration:

  • Standard Adult Dosing: For conditions like symptomatic GERD or short-term ulcer treatment, the typical regimen is 20 mg or 40 mg taken once daily (QD).
  • Higher Doses/Frequency: Regimens for H. pylori eradication require 20 mg twice daily (BID), while Pathological Hypersecretory Conditions (e.g., Zollinger-Ellison Syndrome) may start at 60 mg QD. Total daily doses exceeding 80 mg are required to be administered in divided doses.
  • Duration: Treatment is typically short-term (e.g., 4 to 8 weeks) for acute healing but may be extended to long-term maintenance for conditions like healed Erosive Esophagitis.

Administration and Procedural Rules

Instruction Category Procedural Requirement
Timing Relative to Meals Oral forms must be taken before eating (e.g., before the morning meal).
Physical Handling Delayed-release capsules/tablets must be swallowed whole and not crushed, chewed, or split to protect the enteric coating.
Alternative Intake If swallowing the capsule is difficult, the contents (pellets) may be mixed with a tablespoon of applesauce and swallowed immediately.
Population Rule Pediatric dosing for GERD/EE is determined by the patient’s weight.

Recent Clinical Evidence

Research evidence / Overview of studies for Ulzol

Evidence for Managing GERD Symptoms and Esophageal Healing

Studies evaluated Ulzol in research settings exploring outcomes related to symptoms of Gastroesophageal Reflux Disease (GERD) and outcomes related to the healing of acid-related damage to the esophagus, known as Erosive Esophagitis (EE). The core evidence consists of Randomized Controlled Trials (RCTs) and systematic reviews.

Research explored short-term symptom changes, with most trials observing responses over defined time intervals of 4 to 8 weeks. Some studies explored how outcomes compared against placebo or other agents in the same class. For EE, studies monitored the acute phase of repair using the endoscopic healing rate, which requires visual confirmation of the repair of the mucosal lining.

Evidence for Ulcers and H. Pylori Eradication Regimens

Research examined Ulzol in study regimens for both duodenal and gastric ulcers. It was also explored as a key part of combination therapy regimens designed to study outcomes related to the Helicobacter pylori bacterial infection. Studies primarily examined the H. pylori eradication rate (microbiological cure) and the rate of ulcer resolution over 4 to 8 weeks.

Long-Term Evidence and Areas of Uncertainty

The overall evidence for Ulzol was studied for both short-term symptom management and longer-term observation of recurrence. Maintenance trials often extended up to 6 to 12 months to monitor the frequency of relapse. However, long-term effects are not fully established beyond these intermediate follow-up periods. The evidence highlights what is known—and what is still uncertain—about continuous use over many years.

Research has also examined the use of Ulzol in specific populations, including children (ages 1–16 years). However, evidence is limited regarding its use in very young populations, specifically infants (1 month to 1 year), where defining reliable symptomatic outcomes proved challenging. Evidence quality varies across studies, and it is not yet clear whether H. pylori eradication was associated with subsequent changes in GERD symptoms.

Frequently Asked Questions (FAQ)

Common questions about Ulzol (FAQ)


Q: How long does it usually take for Ulzol to start working?

Official information indicates that Ulzol begins inhibiting the production of stomach acid quite rapidly, often within one hour after the dose is taken. The maximum effect on acid secretion has been observed within about two hours in studies. However, achieving full, steady control of acid often takes up to four days of continuous treatment.


Q: Can Ulzol cause sleepiness or drowsiness?


Drowsiness, also known as somnolence, has been reported as a potential side effect, though it is not classified as common. Official product information lists nervous system effects like headache and uncommon effects such as dizziness (vertigo). Drowsiness or somnolence may affect the ability to drive or operate machinery, and caution may be appropriate.


Q: Is it normal to feel a bit nauseous when first starting Ulzol?


Yes, nausea is listed as a common adverse reaction in regulatory documents. Official information notes that these common gastrointestinal side effects are often transient and may be more noticeable when treatment is first started.


Q: What happens if I forget to take my Ulzol dose?


If an individual remembers the missed dose, it can generally be taken at that time. However, if it is nearly time for the next scheduled dose, the missed dose can be skipped. Individuals should then resume their regular schedule and avoid taking a double dose.


Q: Is Ulzol safe for elderly patients?


Ulzol is used in older adults, though official warnings advise caution, especially with prolonged use. This is due to a documented increased risk of bone fracture, specifically affecting the hip, wrist, or spine, which is associated with long-term use (generally one year or longer).


Q: How long does Ulzol stay in your system after stopping treatment?


The drug itself has a short plasma half-life (the time it takes for half of the drug to be cleared from the bloodstream) of approximately 0.5 to 1 hour, which indicates the rate at which it is cleared from the bloodstream. However, the acid-blocking effect lasts much longer because Ulzol forms a lasting bond with the proton pumps in the stomach.


Q: Can children or teenagers take Ulzol?


Yes, Ulzol is approved for specific acid-related indications in pediatric patients starting at one year of age. It is also approved for use in adolescents, typically using adult dosage guidelines for those approved indications.


Q: Why is Ulzol sometimes taken in the evening?


While the standard single daily dose is usually taken before the morning meal, when a medical condition requires a twice daily (BID) regimen, official guidelines typically involve spacing the doses and taking them before the morning and evening meals.


Q: What are the signs that Ulzol is actually working for my condition?


As Ulzol works to reduce stomach acid, an indication of its effect may be the improvement of acid-related symptoms like heartburn or acid reflux. Regulatory information notes that it may take several days before a patient notices a significant reduction in stomach pain or a marked improvement in symptoms.


Q: Can taking Ulzol increase my sensitivity to the sun?


There have been official reports of skin reactions, including rashes on areas like the cheeks or arms, that may become worse when exposed to the sun. Given these reports, protection from excessive sun exposure may be appropriate.


Q: Does Ulzol have any potential interactions with common antacids?


Regulatory guidelines note that Ulzol can generally be taken with common antacids. This is because using antacids does not interfere with the absorption or effectiveness of the Ulzol medicine.


Q: Can Ulzol cause changes in mood or anxiety?


Official adverse reaction lists mention insomnia (difficulty sleeping) as an uncommon psychiatric disorder associated with Ulzol use. While specific claims about mood changes or anxiety are not detailed, individuals should review the full list of potential nervous system effects with their healthcare provider.


Q: Is it necessary to take Ulzol with food?


It is generally taken on an empty stomach; official guidelines advise administration 30 to 60 minutes before a meal for best results. It is not necessary to take Ulzol with food.


Q: Is it common for Ulzol to cause dry mouth?


Dry mouth is listed as an adverse reaction in the post-marketing experience or as an uncommon side effect for certain formulations of Ulzol. If this side effect occurs, it should be mentioned to a healthcare provider if it becomes bothersome.


Q: Are there any known withdrawal symptoms if Ulzol is stopped suddenly?


While there are no true 'withdrawal' symptoms in the conventional sense, official warnings note that stopping Ulzol abruptly, particularly after a long course of use (over 8 weeks), can lead to rebound acid hypersecretion. This condition may cause a temporary flare-up of acid reflux or GERD symptoms.


Q: Do I need a prescription from a doctor for Ulzol?


Ulzol is available in different strengths and for different uses. Lower strengths are available over-the-counter (OTC) for the treatment of frequent heartburn. However, higher strengths and formulations used for more severe conditions still require a doctor's prescription.


Q: Does Ulzol affect my ability to drive or operate machinery?


The medicine can cause common side effects like headache and uncommon side effects such as dizziness (vertigo). Due to these potential nervous system effects, caution may be appropriate when driving or operating machinery if impairment is experienced.


Q: Is there a generic version of Ulzol available?


Yes, the active ingredient in Ulzol (Omeprazole) is widely available in generic formulations. These generic versions are approved by regulatory agencies and come in both prescription and over-the-counter strengths.


Q: What should I tell my doctor before starting Ulzol?


Individuals should inform their doctor about any existing health issues, such as liver disease or a history of lupus. It is important to report specific severe symptoms, such as unexplained weight loss or blood in vomit or stool, as these may require medical investigation before starting treatment.


Q: What are the signs of an overdose with Ulzol?


Official information regarding overdose notes that while severe outcomes are uncommon, potential signs documented in clinical studies include sedation, nausea, vomiting, and symptoms such as a rapid heartbeat (tachycardia), confusion, and headache.


Q: Does Ulzol have a cumulative effect in the body?


In terms of effectiveness, Ulzol does have a cumulative effect. Regulatory information states that the maximum acid-blocking power of the drug is not immediate and is typically achieved only after taking the medication for approximately four consecutive days.

How should Ulzol be stored and disposed of?

How to Store and Dispose of Ulzol

Official regulatory guidelines mandate specific conditions to ensure the stability and effectiveness of Ulzol capsules and tablets.


Mandatory Storage Requirements

Item Requirement
Temperature Store at or below 30 C (some formulations require below 25 C).
Environmental Protection Must be protected from light and stored in a dry place.
Container Rule Keep in the original package and ensure the container is tightly closed to guard against moisture.
Child Safety The medication must be kept out of the reach of children and pets.

Official Disposal Instructions

Unused or expired Ulzol should be disposed of in accordance with local requirements established by health authorities. Do not dispose of the medication by flushing it down a toilet or washing it down a sink drain unless specifically instructed by local drug take-back programs.

Attention! Always consult to a doctor or pharmacist before using pills or medicines.

Available in countries:

Equivalent of Ulzol found in:

A-Z Index: